News Headlines

  1. Outsourced Pharma Announces San Diego Conference Session Update

    Outsourced Pharma announces an agenda and panelist update for its Outsourced Pharma San Diego conference to be held in La Jolla on August 22 – 23 2017, at the Hyatt Regency La Jolla. Outsourced Pharma is a conference designed for executives at pharma and biotech sponsor companies who rely on contract development and manufacturing organizations to bring their products to market.

  2. Catalent Applied Drug Delivery Institute Partners With Rutgers University To Better Understand The Challenges Of Pediatric Drug Formulation And Delivery

    The Catalent Applied Drug Delivery Institute today announced that it has entered into a collaboration with the Department of Pharmacy Practice at Rutgers University, with a view to identify and address the specific challenges of pediatric formulation and drug delivery.

  3. Recipharm And LIDDS Establish Industrial Manufacturing Capabilities For A Novel Prostate Cancer Product

    Recipharm, the contract development and manufacturing organisation (CDMO), and LIDDS have together set up a manufacturing line for LIDDS’ novel prostate cancer drug, Liproca Depot, at Recipharm in Solna, Sweden.

  4. Almirall Collaborates With ICMAB-CSIC And Leitat Technology Center In Nanomedicine Applied To Dermatology

    Almirall, S.A. announced recently the launch of Nano4Derm, a research project in collaboration with the Institute of Material Science of Barcelona from CSIC (ICMAB-CSIC), and Leitat Technology Center, focused in nanomedicine applied to treat dermatological diseases.

  5. FDA Approves Vosevi For Hepatitis C

    The U.S. Food and Drug Administration recently approved Vosevi to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis. 

  6. Life Science Connect Announces The Acquisition Of Industry Standard Research

    Today Life Science Connect (LSC), a leading B2B marketing services and engagement company, announced the acquisition of Industry Standard Research (ISR), also known as ISR Reports.

  7. UDG Healthcare Announces The Acquisition Of US-Based Healthcare Communications Business For Up To $35M

    UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the acquisition of Cambridge BioMarketing LLC, a US-based healthcare communications business, for a total consideration of up to $35m.

  8. Technology Adoption Fuels Growth For pharma Tech Firm

    Zenith Technologies has strengthened its global workforce, recruiting 100 people over the past year in response to growing demand for manufacturing execution system (MES) and automation technology in the pharma sector.

  9. Facility Available: 49 Mall Drive, Commack, NY 11725

    49 Mall Drive was purchased in 2015 by Ropack Pharma Solutions (RPS). RPS has made the strategic decision to market and sell its solid oral dosage development and manufacturing facility located at 49 Mall Drive, Commack, New York.

  10. UDG Healthcare Announces The Acquisition Of US-Based Healthcare Consultancy Firm, Vynamic

    UDG Healthcare plc (“the Group”), a leading international healthcare services provider, is pleased to announce the acquisition of Vynamic LLC, a US-based healthcare industry management consulting firm.